We are live on ! Find out more
AAP

Aristotle Atlantic Partners Portfolio holdings

AUM $2.14B
1-Year Est. Return 37.01%
This Fund
S&P 500
This Quarter Est. Return
-12.54%
1 Year Est. Return
+37.01%
3 Year Est. Return
+123.74%
5 Year Est. Return
+154.13%
10 Year Est. Return
AUM
$655M
AUM Growth
-$128M
Cap. Flow
-$7.82M
Cap. Flow %
-1.19%
Top 10 Hldgs %
45.75%
Holding
102
New
4
Increased
46
Reduced
19
Closed
10

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$7.19M
2
AYX
Alteryx Inc
AYX
+$5.65M
3
MRK icon
Merck
MRK
+$3.71M
4
TECH icon
Bio-Techne
TECH
+$2.1M
5
CI icon
Cigna
CI
+$1.94M

Sector Composition

Rank Sector Weight
1 Healthcare 25.71%
2 Technology 25.24%
3 Industrials 11.67%
4 Consumer Discretionary 9.74%
5 Financials 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADPT icon
26
Adaptive Biotechnologies
ADPT
$3.61B
$10.3M 1.57%
370,841
+7,232
+2% +$202K
XOM icon
27
ExxonMobil
XOM
$642B
$10.3M 1.57%
270,124
-14,672
-5% -$810K
GH icon
28
Guardant Health
GH
$19.3B
$10.2M 1.57%
147,242
+4,058
+3% +$311K
AMT icon
29
American Tower
AMT
$77.7B
$8.71M 1.33%
40,000
DXCM icon
30
DexCom
DXCM
$28.3B
$7.69M 1.17%
+114,168
New +$7.1M
BMY icon
31
Bristol-Myers Squibb
BMY
$128B
$6.83M 1.04%
122,544
+760
+0.6% +$46.5K
NXPI icon
32
NXP Semiconductors
NXPI
$67.6B
$6.5M 0.99%
78,318
-150
-0.2% -$17.6K
AAPL icon
33
Apple
AAPL
$4.95T
$6.45M 0.98%
101,420
+14,672
+17% +$1.08M
AYX
34
DELISTED
Alteryx Inc
AYX
$5.02M 0.77%
52,733
-45,495
-46% -$5.65M
PCH
35
DELISTED
PotlatchDeltic
PCH
$4.76M 0.73%
151,661
COO icon
36
Cooper Companies
COO
$13.7B
$4.41M 0.67%
64,000
PH icon
37
Parker-Hannifin
PH
$124B
$4.25M 0.65%
32,770
-161
-0.5% -$29.1K
FIS icon
38
Fidelity National Information Services
FIS
$22.3B
$3.9M 0.6%
32,050
+8,217
+34% +$1.14M
MUSA icon
39
Murphy USA
MUSA
$11.3B
$3.66M 0.56%
43,413
MUR icon
40
Murphy Oil
MUR
$5.38B
$3.06M 0.47%
498,655
-3,200
-0.6% -$58.8K
ABT icon
41
Abbott
ABT
$182B
$2.85M 0.43%
36,081
+3,173
+10% +$265K
BAC icon
42
Bank of America
BAC
$436B
$2.32M 0.35%
109,245
-11,165
-9% -$335K
BMRN icon
43
BioMarin Pharmaceuticals
BMRN
$11.6B
$2.11M 0.32%
25,000
BDX icon
44
Becton Dickinson
BDX
$43.8B
$1.99M 0.3%
8,861
+598
+7% +$148K
CMCSA icon
45
Comcast
CMCSA
$80.9B
$1.85M 0.28%
53,680
+16,454
+44% +$694K
BA icon
46
Boeing
BA
$167B
$1.82M 0.28%
12,211
+469
+4% +$128K
NSC icon
47
Norfolk Southern
NSC
$77.1B
$1.8M 0.28%
12,342
+784
+7% +$145K
IFF icon
48
International Flavors & Fragrances
IFF
$19.5B
$1.68M 0.26%
16,466
AVGO icon
49
Broadcom
AVGO
$1.82T
$1.67M 0.25%
70,310
+4,960
+8% +$140K
NEE icon
50
NextEra Energy
NEE
$185B
$1.62M 0.25%
26,884
+2,244
+9% +$141K

Similar funds

Aristotle Atlantic Partners's Q1 2020 Portfolio in Review

As of Q1 2020, Aristotle Atlantic Partners held 102 positions worth $655M, down 16% from $783M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Aristotle Atlantic Partners's Q1 2020 filing shows 4 new, 46 increased, 19 reduced and 10 closed positions. Its largest new stake was DexCom: 114,168 shares worth $7.69M. The largest sale was NVIDIA, an estimated $7.19M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

  • Aristotle Atlantic Partners's largest Q1 2020 buy was DexCom: 114,168 shares worth $7.69M.
  • Aristotle Atlantic Partners added most to Fidelity National Information Services in Q1 2020, an estimated $1.14M increase.
  • Aristotle Atlantic Partners's biggest Q1 2020 reduction was NVIDIA, cutting an estimated $7.19M.
  • Aristotle Atlantic Partners fully exited Supernus Pharmaceuticals in Q1 2020, selling an estimated $993K.
  • Aristotle Atlantic Partners's ten largest holdings make up 46% of its $655M portfolio in Q1 2020.
  • Aristotle Atlantic Partners opened 4 new positions and closed 10 in Q1 2020.
  • Aristotle Atlantic Partners's portfolio value fell 16% quarter-over-quarter to $655M.

Based on Aristotle Atlantic Partners's 13F filing for Q1 2020, filed 14 May 2020.